$CUE:NASDA - CUE BIOPHARMA - 100% run over the last month.

30 thg 4, 2020

Cue has been having a great run of late - up 100% over the last month and up a bit over 200% over the last 6 months. Its been running pretty hard for a while so might be overextended, but I like what they do and could be worth a watch. Be careful of pullbacks.

Cue Biopharma, a clinical-stage biopharmaceutical company, is engineering a novel class of injectable biologics to selectively engage and modulate targeted T cells within the body to transform the treatment of cancer and autoimmune diseases. The company’s proprietary platform, Immuno-STAT™ (Selective Targeting and Alteration of T cells), is designed to harness the body’s intrinsic immune system without the need for ex vivo manipulation.